Daily aspirin use following cardiovascular intervention is commonplace and creates concern regarding bleeding risk in patients undergoing surgery. Despite its cardio-protective role, aspirin is often discontinued 5-7 days prior to major surgery due to bleeding concerns. Single institution studies have investigated perioperative outcomes of aspirin use in robotic partial nephrectomy (RPN). We sought to evaluate the outcomes of perioperative aspirin (pASA) use during RPN in a multicenter setting.

中文翻译：

---

围手术期阿司匹林的使用与机器人部分肾切除术的出血并发症有关。

心血管干预后每日服用阿司匹林是司空见惯的，并引起人们对接受手术的患者出血风险的担忧。尽管阿司匹林具有心脏保护作用，但由于出血问题，通常在大手术前 5-7 天停用阿司匹林。单一机构研究调查了在机器人肾部分切除术 (RPN) 中使用阿司匹林的围手术期结果。我们试图在多中心环境中评估 RPN 期间围手术期阿司匹林 (pASA) 使用的结果。